Conflict of interest statement: The authors declare no conflicts of interest. Thefounding sponsors had no role in the design of the study; the collection,analysis, or interpretation of data; the writing of the manuscript; or thedecision to publish the results.133. Diagnostics (Basel). 2018 Jul 9;8(3). pii: E45. doi: 10.3390/diagnostics8030045.Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A NarrativeReview.Stecco A(1), Trisoglio A(2), Soligo E(3), Berardo S(4), Sukhovei L(5), CarrieroA(6).Author information: (1)Ospedale Maggiore della Carità di Novara, Istituto di Radiodiagnostica edInterventistica, Università del Piemonte Orientale, Amedeo Avogadro, CorsoGiuseppe Mazzini 18, 28100 Novara, Italy. a.stecco@libero.it.(2)Ospedale Maggiore della Carità di Novara, Istituto di Radiodiagnostica edInterventistica, Università del Piemonte Orientale, Amedeo Avogadro, CorsoGiuseppe Mazzini 18, 28100 Novara, Italy. alessandratrisoglio@outlook.it.(3)Ospedale Maggiore della Carità di Novara, Istituto di Radiodiagnostica edInterventistica, Università del Piemonte Orientale, Amedeo Avogadro, CorsoGiuseppe Mazzini 18, 28100 Novara, Italy. eleonora.soligo@alice.it.(4)Ospedale Maggiore della Carità di Novara, Istituto di Radiodiagnostica edInterventistica, Università del Piemonte Orientale, Amedeo Avogadro, CorsoGiuseppe Mazzini 18, 28100 Novara, Italy. berardo.sara@gmail.com.(5)Ospedale Maggiore della Carità di Novara, Istituto di Radiodiagnostica edInterventistica, Università del Piemonte Orientale, Amedeo Avogadro, CorsoGiuseppe Mazzini 18, 28100 Novara, Italy. lid.sukhovei@gmail.com.(6)Ospedale Maggiore della Carità di Novara, Istituto di Radiodiagnostica edInterventistica, Università del Piemonte Orientale, Amedeo Avogadro, CorsoGiuseppe Mazzini 18, 28100 Novara, Italy. profcarriero@virgilio.it.Whole body magnetic resonance imaging (MRI) with diffusion-weighted imaging(WB-MRI-DWI) is currently emerging as a diagnostic technique in the evaluation ofbone metastases from breast, prostate, lung, thyroid, and melanoma tumors. Themost relevant articles regarding the detection of solid tumor bone metastaseswith MRI have been reviewed and cited. The imaging methods currently used in the detection of bone metastases are bone scintigraphy, computed tomography (CT), andpositron emission tomography (PET/CT) with 2-deoxy-2-[fluorine-18]fluoro-d-glucose (18F-FDG PET/CT). WB-MRI-DWI allows qualitative and quantitativeevaluation of focal lesions through signal intensity evaluation on DWI images andthe reconstruction of the apparent diffusion coefficient (ADC) map. In prostateand breast cancer, WB-MRI-DWI is useful in assessing the response of bone lesionsto therapy and to detecting early non-responders, while in lung cancer the methodshows a similar sensitivity to 18F-FDG PET/CT in the detection of bonemetastases. In bone metastases of thyroid tumors and melanoma, the WB-MRI-DWIshows a higher sensitivity when compared to 18F-FDG PET/CT. With astandardization of the WB-MRI-DWI protocol, this method seems to play animportant role in the diagnosis of bone solid tumor metastases.DOI: 10.3390/diagnostics8030045 PMID: 29987207 